Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study. Palmier E, De Miguel R, Montejano R, Busca C, et al. HIV Med 2023 May 16. doi: 10.1111/hiv.13500.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Palmier E, De Miguel R, Montejano R, Busca C, et al. Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study. HIV Med 2023 May 16. doi: 10.1111/hiv.13500.
PMID: 37194419